Christian Wichert named new CEO of AMSilk

The company, which produces biomaterials based on silk proteins, stated that Wichert's arrival comes as it moves towards scaling up and commercialising its technology following the entry of its fibre applications into the market.

In his new role, Wichert will be tasked with boosting AMSilk's commercial operations and expanding the reach of its proprietary silk protein technology, which utilises precision fermentation, into a broader range of applications and markets.

AMSilk said that Wichert will place particular emphasis on commercial outcomes within its Consumer Care Solutions division.

He joins AMSilk with over 25 years of leadership experience in international business settings. Most recently, Wichert was chief executive officer at Evolva, a Swiss biotechnology company listed on the public markets.

During his tenure at Evolva, he gained capital markets experience and managed the company through a period of strategic change, culminating in its sale to Danstar Ferment AG/Lallemand Group.

He also held senior positions across the speciality chemicals sector, consumer packaged goods, MedTech, and industrial biotechnology, all areas which AMSilk has identified as important for i

Fuente original: Yahoo Finance (https://finance.yahoo.com/healthcare/articles/christian-wichert-named-ceo-amsilk-105236786.html)